Patients with 22q11 deletion syndrome (22q11.2DS) present, in about 75% of cases, typical patterns of cardiac defects, with a particular involvement on the ventricular outflow tract and great arteries. However, in this genetic condition the dimensions of the pulmonary arteries (PAs) never were specifically evaluated.
INTRODUCTION
Patients with 22q11.2 deletion syndrome (22q11.2DS) present specific conotruncal defects (1) (2, 3) including tetralogy of Fallot with or without pulmonary atresia (4, 5) , Truncus Arteriosus (6, 7) , Interrupted Aortic Arch (8, 9) , other aortic arch anomalies or minor congenital heart defects (10, 11) , and ventricular septal defect (12) .
In more than 90% of them a 3 Mb deletion was detected (13) , spanning LCR22-A to LCR22-D that contains at least 30 genes including TBX1 in the proximal region. This encodes a T-box transcription factor identified as the major player of this syndrome throughout both modeling mice (14) (15) (16) (17) and mutational analysis in patients (18) . In Tbx1 mutant mice some cardiovascular anomalies similar to those found in 22q11.2DS patients have been described (15, 19) . These observations can be explained by the fact that Tbx1 is expressed in precursors of outflow tract cells and its loss of function reduces cell contribution to the outflow tract. (20) (21) (22) .
Additional anomalies of pulmonary arteries (PAs) including diffuse hypoplasia, discontinuity, and crossing, were sporadically reported in 22q11.2DS patients (1, 3, (23) (24) (25) (26) but not extensively studied. The aim of this study is to investigate the dimensions of both PAs in patients with this syndrome. In addition, we have analyzed the PAs diameters in Tbx1 knockout mice and found that its haploinsufficiency is associated PAs asymmetry,indicating that this gene is the candidate for the PA phenotype reported here. Mouse studies were carried out at the Institute of Genetics and Biophysics under the auspices of the animal protocol 257/2015-PR (licensed to the AB lab) reviewed, according to Italian regulations, by the Italian Istituto Superiore di Sanità and approved by the Italian Ministero della Salute. The laboratory applies the "3Rs" principles to minimize the use of animals and to limit or eliminate suffering.
MATERIALS AND METHODS

Echocardiographic study
Data patients were ascertained from our hospital database for patients attending the Pediatric According to BSA, Z score values were reported for M Mode results and for 2D PA branches diameters. Images were digitally stored and measurement were made offline according to the American Society of Echocardiography guidelines by two independent readers for both centers (GM, PV, and GC, EP).
Mouse studies
To perform phenotypic analyses, Tbx1 +/mice (15) were intercrossed and pregnant females (3-6 months-old) were sacrificed using CO 2 inhalation at plug day (E) 18.5, and fetuses harvested.
Prior to observation. fetuses were washed in PBS and dissected under a Zeiss Stemi 2000-CS Stereo
Microscope. Photographs were taken using a Z-stack software. In order to improve the view, we injected ink into the pulmonary trunk. Overall we have dissected and examined the cardiovascular phenotype of 8 wild type (WT), 37 heterozygous (Tbx1 +/-), and 6 null fetuses (Tbx1 -/-). To reveal Tbx1-expressing cells and their descendants. we crossed Tbx1 Cre/+ mice (27) 
RESULTS
22q11.2DS patients have smaller LPAs than controls, independently from intracardiac anomalies.
We identified 58 patients with isolated abnormalities of aortic arch or epiaortic vessels disease according to our criteria. Table 1 summarizes major clinical findings. All 22q11.2DS patients had variable expressivity and incomplete penetrance of dysmorphic features typical of the syndrome. A similar group of healthy volunteers was analyzed ( Table 2 ). Using echocardiography, we have 6 measured the diameter of PAs in a healthy subgroup and we found that LPAs were smaller than RPAs (9.4± 2.4 vs 10.0±2.8. P < 0.05). This finding was confirmed also in in 22q11.2DS cases, which exhibited LPAs measurements smaller than RPAs (8.2± 2.4 vs 9.4±2.4; P=0.016) and in Z score (-1.57± 1.2 vs -0.65± 1.0; P<0.001). No differences were found comparing diameters of RPAs in cases and controls. In contrast, LPA/RPA ratios showed a significant difference between the two groups: 0.80±0.09 in cases vs 0.95±0.11 in controls (P < 0.001) (Tabs. 1-2).
Tbx1 haploinsufficiency is associated with smaller LPAs in mice.
TBX1 is the candidate gene for many of the clinical and developmental features of 22q11.2DS patients including aortic arch anomalies and intracardiac anomalies. However, to our knowledge, anomalies of PAs in mouse mutants have not been reported to date. To understand whether loss of Tbx1 may be a candidate also for the observed size asymmetry of the PAs, we measured them in Tbx1 +/+ , Tbx1 +/-, and Tbx1 -/-E18.5 fetuses in a homogeneous congenic background C57Bl6/N. Fig. 1 . In WT (Tbx1 +/+ ) fetuses, we found no significant difference (Mann-Whitney test) in the diameters of LPAs and RPAs (ratio LPA/RPA=0.92. n=8). However, in Tbx1 +/fetuses, the LPAs were significantly smaller than the RPAs (P=0.0016, ratio LPA/RPA=0.79, n=37). Similarly, the Tbx1 -/fetuses also had significantly different PAs (P=0.004, ratio LPA/RPA=0.63, n=6). All WT fetuses had normal arch and epiaortic vessels. Of the 37 heterozygous animals analyzed, 14 had aberrant origin of the right subclavian artery (37.8%) of which, 2 had high aortic arch, 3 interrupted aortic arch type B, and 1 right aortic arch. All 6 Tbx1 -/fetuses had truncus arteriosus, as previously described (15) . In all Tbx1 -/fetuses the pulmonary arteries rose separately from the posterior wall of the arterial trunk proximal to the branches of aortic arch (Truncus Arteriosus -type II of Collett and Edwards or type A2 of Van Praagh).
Results are plotted in
Tbx1-expressing cells contribute to structural components of the pulmonary arteries. 7 To provide insights as to how Tbx1 may affect the development of the PAs, we looked into the expression of the gene. To do this. we used genetic marking of Tbx1-expressing cells and their descendants in Tbx1 cre/+ ; Rosa mT/mG embryos in which these cells are marked by membrane-bound green fluorescent protein (GFP). At E10.5. the PAs connect the aortic sac (through the proximal end of the 6th pharyngeal arch arteries) to the lung buds. GFP+ cells were observed in the mesoderm adjacent to the arteries, in the adjacent dorsal pericardial wall, and in the inner, endothelial layer of the arteries (Fig. 2) . In the mature PAs at E18.5, the distribution of GFP+ cells were observed in the endothelial layer and in the outer mesenchymal tissue adjacent to the arteries. We did not observe contribution of GFP+ cells in the smooth muscle layer of the arteries, in contrast to the pulmonary trunk.
DISCUSSION
The junction between LPA and DA is a crucial segment for the cardiovascular development and it is frequently affected in patients with conotruncal anomalies (29 -32) . Also in healthy people a smaller diameters of the LPA was reported in comparison with the RPA. Moreover, malformations of the pulmonary arteries, in particular of the left, including stenosis, diffuse hypoplasia, discontinuity or crossing, are not unusual in children with 22q11.2DS with or without conotruncal defects (33, 34, 3, 35, 36, 25, 24, 37) . The detailed morphogenesis of the pulmonary arteries is not definitively ascertained. However, recent studies on mouse and human embryos contribute to better clarify this difficult topic (38, 39) . According to recent data, while on the right side the VI pharyngeal arch artery disappears, on the left side it is formed by a ventral bud from the aortic sac and by a dorsal bud from the dorsal aorta. This ventral bud, with the contribution from the post-branchial pulmonary plexus, forms the LPA. The dorsal bud on the left side of the VI aortic arch forms the ductus arteriosus (DA), which is in continuity with the LPA. Our echocardiographic studies show that even in the absence of conotruncal defects, patients with 22q11.2DS have a smaller LPA compared to healthy subjects. 8 Our data demonstrate that the LPA is smaller than the RPA in Tbx1 +/fetuses but not in WT fetuses, indicating that Tbx1 haploinsufficiency affects significantly the LPA size. Expression data indicate that structural components of the PAs (endothelium and adventitia) derive from Tbx1expressing cells. This is also true for the DA, thus suggesting that Tbx1 is involved in the development or growth of this cardiovascular segment. Mouse data are in agreement with echocardiographic measurements on patients with 22q11.2DS.
It is of interest to note that in mice Tbx1 haploinsufficiency affects the IV but not the VI aortic arch artery development (19.40) , while in Tbx1 -/embryos the VI does not develop (19) . The phenotype that we have described here suggest that a) the absence of the VI aortic arches does not have a dramatic impact on PAs development, and b) the reduced size of the LPA is probably not secondary to abnormalities of the VI aortic arch. The finding that Tbx1-expressing cells contribute to structural component of the PAs provides a support for a direct, though limited role of Tbx1 in determining the size of the PAs.
In the past, stenosis, diffuse hypoplasia or atresia of the proximal LPA was mainly ascribed to the extension of the ductal tissue into the LPA lumen. This pathogenetic mechanism known as "coarctation of the LPA" maintains its validity. However. our data suggest that molecular causes may influence the morphogenesis of this peculiar cardiovascular region, in particular the effect of Tbx1 in this region may influence the morphology and dimensions of the LPA and its loss of function may cause some of its specific defects.
The reduced dimensions of LPA observed in our patients could be considered a subclinical sign associated with 22q11.2DS. We suggest that in subjects with 22q11.2DS the junction between the DA and the LPA may be at risk of additional anomalies and deserves specific diagnostic investigation.
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FIGURE LEGENDS
Figure 1
Distribution of pulmonary arteries measurements in WT, Tbx1 +/-, and Tbx1 -/fetuses at E18.5.
Figure 2
Transverse section of a E10. to the pulmonary myocardium, pulmonary trunk (PT) and pulmonary valves, but superficial contribution (endothelial and adventitial) to other great vessels, including the ductus arteriosus (DA). which appears to have a more dense endothelial contribution. aAo: ascending aorta. C: immunofluorescence of a transverse section of a E18.5 Tbx1 cre/+ ; Rosa mT/mG . Anti GFP staining is shown in green, anti PECAM1 staining (endothelial-specific) is shown in red. DAPI staining (cell nuclei) is shown in blu. C'-C'': green and red channels are shown separately. aAo: ascending aorta;
PT: pulmonary trunk and pulmonary leaflets; LPA, RPA: left and right pulmonary arteries. Table 1 . Echocardiographic data of 22q11.2DS patients without intracardiac defects. 
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